The objective of this study was to explore attitudes and beliefs of school-based health center (SBHC) staff about overdose prevention education and medication for opioid use disorder (MOUD) in SBHCs.
Methods:
We interviewed 13 SBHC staff using a semi-structured interview guide covering the following: youth substance use training, beliefs in and attitudes about overdose prevention, providing MOUD, and interactions with students’ families. A hybrid deductive and inductive approach was used to conduct thematic analysis.
Results:
Four themes emerged: (1) limited experience in providing care or education on opioids and overdose, (2) barriers to implementation of education and MOUD including school administration and operational concerns, (3) overdose prevention and treatment is consistent with existing practices, and (4) confidentiality as a facilitator and barrier of overdose prevention education and MOUD provision.
Conclusion:
SBHCs are uniquely positioned to provide overdose prevention education and MOUD. Developing, testing, and implementing both interventions should be made in collaboration with youth and SBHC staff.
GoldstickJECunninghamRMCarterPM.Current causes of death in children and adolescents in the United States. N Engl J Med. 2022;386(20):1955-1956. doi:10.1056/NEJMc2201761
2.
TanzLJDinwiddieATMattsonCLO’DonnellJDavisNL.Drug overdose deaths among persons aged 10-19 years—United States, July 2019-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(50):1576-1582. doi:10.15585/mmwr.mm7150a2
3.
BohmMKClaytonH.Adolescent prescription opioid misuse, illicit opioid use and overdose. Online J Public Health Inform. 2019;11(1):e422. doi:10.5210/ojphi.v11i1.9906
4.
HermansSPSamiecJGolecATrimbleCTeaterJHallOT.Years of life lost to unintentional drug overdose rapidly rising in the adolescent population, 2016-2020. J Adolesc Health. 2023;72(3):397-403. doi:10.1016/j.jadohealth.2022.07.004
5.
RenehanCMWigginsMPuppalaR, et al. A scoping review of youth overdose prevention interventions. J Addict Med. Published online May 9, 2025. doi:10.1097/ADM.0000000000001501
6.
HadlandSEKimmelSDYanS, et al. Buprenorphine treatment duration and adherence among youth and subsequent health outcomes. Pediatrics. 2025;156(6):e2025071147. doi:10.1542/peds.2025-071147
7.
WalleyAYXuanZHackmanHH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174. doi:10.1136/bmj.f174
8.
RazaghizadAWindleSBFilionKB, et al. The effect of overdose education and naloxone distribution: an umbrella review of systematic reviews. Am J Public Health. 2021;111(8):e1-e12. doi:10.2105/AJPH.2021.306306
9.
LarochelleMRBernsonDLandT, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137-145. doi:10.7326/M17-3107
10.
CoffinPOSullivanSD.Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1-9. doi:10.7326/0003-4819-158-1-201301010-00003
11.
WakemanSELarochelleMRAmeliO, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622. doi:10.1001/jamanetworkopen.2019.20622
12.
ChhatwalJMuellerPPChenQ, et al. Estimated reductions in opioid overdose deaths with sustainment of public health interventions in 4 US states. JAMA Netw Open. 2023;6(6):e2314925. doi:10.1001/jamanetworkopen.2023.14925
13.
CamengaDRColon-RiveraHAMuvvalaSB.Medications for maintenance treatment of opioid use disorder in adolescents: a narrative review and assessment of clinical benefits and potential risks. J Stud Alcohol Drugs. 2019;80(4):393-402.
14.
American Academy of Pediatrics – COMMITTEE ON SUBSTANCE USE AND PREVENTION. Medication-assisted treatment of adolescents with opioid use disorders. Pediatrics. 2016;138(3):e20161893. doi:10.1542/peds.2016-1893
15.
McCartyDChanBBuchheitBMBougatsosCGrusingSChouR.Effectiveness of and acces to medications for opioid use disorder for adolescents and young adults: a scoping review. J Addict Med. 2022;16(3):e157-e164. doi:10.1097/ADM.0000000000000898
16.
MauroPMGutkindSAnnunziatoEMSamplesH.Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019. JAMA Netw Open. 2022;5(3):e223821. doi:10.1001/jamanetworkopen.2022.3821
17.
HadlandSEAalsmaMCAkgülS, et al. Medication for adolescents and young adults with opioid use disorder. J Adolesc Health. 2021;68(3):632-636. doi:10.1016/j.jadohealth.2020.12.129
Massachusetts School Based Health Alliance. Locations. Massachusetts school based health alliance. 2024. Accessed July 24, 2024. https://www.masbha.org/locations
TongASainsburyPCraigJ.Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349-357. doi:10.1093/intqhc/mzm042
23.
NealeJ.Iterative categorization (IC): a systematic technique for analysing qualitative data. Addict Abingdon Engl. 2016;111(6):1096-1106. doi:10.1111/add.13314
HadlandSESchmillDMBagleySM.Anticipatory guidance to prevent adolescent overdoses. Pediatrics. 2024;153(5):e2023065217. doi:10.1542/peds.2023-065217
26.
TerranellaAGuyGJrMikoszC.Naloxone dispensing to youth ages 10-19: 2017-2022. Pediatrics. 2024;154:e2023065137. doi:10.1542/peds.2023-065137
27.
MadsonMBSchumacherJABaerJSMartinoS.Motivational interviewing for substance use: mapping out the next generation of research. J Subst Abuse Treat. 2016;65:1-5. doi:10.1016/j.jsat.2016.02.003
28.
JensenCDCushingCCAylwardBSCraigJTSorellDMSteeleRG.Effectiveness of motivational interviewing interventions for adolescent substance use behavior change: a meta-analytic review. J Consult Clin Psychol. 2011;79(4):433-440. doi:10.1037/a0023992
29.
DiClementeCCCornoCMGraydonMMWiprovnickAEKnoblachDJ.Motivational interviewing, enhancement, and brief interventions over the last decade: a review of reviews of efficacy and effectiveness. Psychol Addict Behav J Soc Psychol Addict Behav. 2017;31(8):862-887. doi:10.1037/adb0000318
HarrisBRRichJH.Upstream prevention of opioid misuse in school-based health centers: provider attitudes, perceptions, and practice. J Soc Work Pract Addict. 2022;22(3):200-211. doi:10.1080/1533256X.2021.1935153.
33.
GoddardAKoneskyABorkowskiVEtcherL.Show Me The Money. . .Saved! Cost savings from acute asthma care in the school-based health center. J Sch Nurs. 2022;38(2):210-219. doi:10.1177/1059840520986951
34.
GeierstangerSPAmaralGMansourMWaltersSR.School-based health centers and academic performance: research, challenges, and recommendations. J Sch Health. 2004;74(9):347-352. doi:10.1111/j.1746-1561.2004.tb06627.x
KnopfJAFinnieRKCPengY, et al. School-based health centers to advance health equity. Am J Prev Med. 2016;51(1):114-126. doi:10.1016/j.amepre.2016.01.009
38.
BagleySMVenturaASLasserKEMuenchF.Engaging the family in the care of young adults with substance use disorders. Pediatrics. 2021;147(suppl 2):S215-S219. doi:10.1542/peds.2020-023523C
39.
BagleySMSchoenbergerSFdellaBittaV, et al. An exploration of young adults with opioid use disorder and how their perceptions of family members’ beliefs affects medication treatment. J Addict Med. 2022;16(6):689-694. doi:10.1097/ADM.0000000000001001
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
